KLF4 is supposed to be crucial for the integrity of the blood-tumor barrier because it enhances the promoter activities of tight junction proteins (TJPs), including ZO-1, occludin, and Claudin5 in the glioma endothelial cells [15]. This evidence concerns the gene OCLN and neoplasm.